Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning recent discussions in Washington on potential drug pricing legislation in a reconciliation package.
The HealthCare Institute of New Jersey (HINJ) has announced new officers of its Board of Trustees and the leadership of its Steering Committee, effective July 1.
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer (Published in the print edition of the Asbury Park Press on Friday, May
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer Manufacturers frequently offer rebates that are passed through to consumers to reduce their
Trenton, February 14, 2022 ― “While we await the opportunity to review the actual bills that Governor Murphy proposed today, we look forward to working
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer New Jersey’s research-based biopharmaceutical industry is constantly developing new cures and treatments that benefit
Steve Issenman
Senior V.P.
732-729-9621
issenman@hinj.org
HealthCare Institute of New Jersey (HINJ)
10 W. Lafayette Street
Trenton, NJ 08608
Phone: 732-729-9619
©2025. HealthCare Institute of New Jersey (HINJ). All rights reserved.
